Synaptic Vulnerability Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
This page provides comprehensive information about the cell type. See the content below for detailed information.
Synaptic vulnerability neurons are neuronal populations that exhibit early and pronounced synaptic dysfunction in neurodegenerative diseases. These neurons undergo synaptic loss, which correlates strongly with cognitive decline.
- Synaptophysin: Presynaptic vesicle protein
- PSD-95: Postsynaptic density scaffold
- SNARE proteins: Synaptic vesicle fusion
- GluR1/2: AMPA receptor subunits
- NR1/NR2: NMDA receptor subunits
- Synaptogyrin: Vesicle cycling
- Synuclein: Presynaptic terminal
- Cav2.1: P/Q-type calcium channels
- Rab3: Synaptic vesicle regulation
-
Hippocampal CA3-CA1 Schaffer collateral synapses
- Early dysfunction in AD
- NMDA receptor alterations
- Memory circuit disruption
-
Entorhinal cortex layer II neurons
- First-order input disruption
- Perforant path alterations
-
Cortical pyramidal neuron synapses
- Layer-specific vulnerability
- Dendritic spine loss
- Neuromuscular junctions
- NMJ dismantling
- Synaptic detachment
- Amyloid-β toxicity: Direct synaptic binding
- Tau dysfunction: Spread to synapses
- Oxidative stress: Membrane damage
- Glutamate excitotoxicity: Calcium overload
- Neuroinflammation: Synaptic phagocytosis
- Presynaptic dysfunction: Vesicle depletion
- Postsynaptic alterations: Receptor internalization
- Spine loss: Structural instability
- Energy failure: Synaptic activity impaired
- C1q tagging: Classical complement pathway
- C3 activation: Opsonization
- Microglial phagocytosis: Synaptic stripping
- NMDA receptor modulators: Memantine
- AMPA receptor stabilizers: CX516
- Synaptic vesicle protein enhancement: Gene therapy
- Anti-amyloid: Reduce synaptic Aβ
- Anti-tau: Prevent synaptic tau
- Complement inhibitors: C1q, C3 blockers
- CSF synaptic proteins (SNAP-25, synaptotagmin)
- PET synaptic density imaging
- Postmortem synaptic counts
The study of Synaptic Vulnerability Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Selkoe, D.J. (2002). Alzheimer's disease is a synaptic failure. Science, 298(5594), 789-791.
- Shankar, G.M., et al. (2008). Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nature Medicine, 14(8), 837-842.
- Terry, R.D., et al. (1991). Synaptic loss in the entorhinal cortex in Alzheimer disease. Annals of Neurology, 29(6), 673-681.
- Hong, S., et al. (2016). Complement and microglia mediate early synapse loss in Alzheimer mouse models. Cell, 165(4), 921-935.
- Scheff, S.W., et al. (2006). Synaptic alterations in CA1 in mild Alzheimer disease. Annals of Neurology, 60(2), 191-202.